Signal active
Organization
Contact Information
Overview
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
The company was founded in 2019 and based in Durham, North Carolina.
About
Biotechnology, Health Care, Wellness, Therapeutics
2019
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Tavros Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Wellness, Therapeutics sector. The company focuses on Biotechnology and has secured $1.3B in funding across 48 round(s). With a team of 1-10 employees, Tavros Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Corporate Round - Tavros Therapeutics, raised $17.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
3
1
0
$28.0M
Details
2
Tavros Therapeutics has raised a total of $28.0M in funding over 2 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | 3.0M | ||
2022 | Seed | 7.5M |
Investors
Tavros Therapeutics is funded by 10 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Tavros Therapeutics | - | FUNDING ROUND - Tavros Therapeutics | 7.5M |
KdT Ventures | - | FUNDING ROUND - KdT Ventures | 7.5M |
Tavros Therapeutics | - | FUNDING ROUND - Tavros Therapeutics | 17.5M |
Vividion Therapeutics | - | FUNDING ROUND - Vividion Therapeutics | 17.5M |
Recent Activity
There is no recent news or activity for this profile.